Sreesha Srinivasa

Sreesha Srinivasa

Company: Oblique Therapeutics

Job title: Chief Development Officer

Seminars:

Live Panel Q&A – Ask the Speakers Your Burning Questions 12:50 pm

Read more

day: Day Two

Targeting KRAS with Mutant Selective Monoclonal Antibodies 12:25 pm

Generation of mutant selective monoclonal antibodies Functional characterization of antibodies Anti-tumor activity in a xenograft tumor modelRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.